Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors. (Q51104155)

29 March 2018

title

Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors. (English)

1 reference

29 March 2018

systemic lupus erythematosus

0 references

1 reference

0 references

author name string

Sallai KK

1

1 reference

29 March 2018

Nagy E

2

1 reference

29 March 2018

Bodó I

3

1 reference

29 March 2018

Mohl A

4

1 reference

29 March 2018

Gergely P

5

1 reference

29 March 2018

publication date

1 May 2007

1 reference

29 March 2018

Scandinavian Journal of Rheumatology

published in

1 reference

29 March 2018

volume

36

1 reference

29 March 2018

issue

3

1 reference

29 March 2018

page(s)

198-205

1 reference

29 March 2018

The systemic nature of the antiphospholipid syndrome

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Molecular pathogenesis of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

The impact of the inflammatory response on coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Blood-borne tissue factor: another view of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Could elevated C-reactive protein in patients with obstructive sleep apnea be due to obesity per se?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Deficiency of protein C in congenital thrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Thromboepidemiology: identifying patients with heritable risk for thrombin-mediated thromboembolic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Elevated clotting factor levels and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

A prospective study of the incidence of deep-vein thrombosis within a defined urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

The lupus anticoagulant/antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

World distribution of factor V Leiden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Population genetics of factor V Leiden in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Cerebral venous thrombosis with lupus anticoagulants. Report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Thromboembolism in paediatric lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740601089283

10.1080/03009740601089283

21 January 2018

Identifiers

DOI

1 reference

29 March 2018

PubMed ID

17657674

1 reference

29 March 2018